The cannabis industry in the U.S. has long been centered around states like Colorado and Oregon, but now, marijuana sales in Illinois and its neighboring states east of the Mississippi River are poised to rival those out west.
The U.S. cannabis market is staring down massive growth, with sales that are expected to reach $22.7 billion by 2023, including $16.8 billion in recreational sales, according to a report out Tuesday from Chicago-based cannabis research firm Brightfield Group. Political support is growing around legalization efforts, and medical programs are expanding around the country. Continue reading “East Coast Marijuana Market Could Rival Colorado’s in Coming Years”→
If you’re a value investor then you are probably terrified of the cannabis sector.
There’s good reason for that. After a few years of big gains, many of the most popular cannabis stocks are trading with sky-high valuations. That leaves traders asking – are cannabis stocks overvalued?
Cannabis concentrates is the fastest growing cannabis subsector. That’s what leading cannabis research firm Arcview Research says in a recent report published with BDS Analytics.
Arcview projected that cannabis concentrate sales would grow 49% in the second half of 2018, reaching $3 billion for the year. Looking forward, Arcview predicts that annual concentrate sales will hit $8.4 billion by 2022, more than doubling in the next four years.
California is paying a price for the shaky rollout of its legal marijuana market.
State budget documents released Thursday show the Newsom administration is sharply scaling back what it expects to collect in cannabis tax revenue through June 2020 — a $223-million cut from projections just four months ago.
It is easily the biggest misconception about cannabis stocks. It’s preventing millions of people from capitalizing on the greatest investment opportunity of my lifetime, and every day the sector rises it only gets worse.
What am I talking about? It’s the #1 question we receive at Cannabis Stock Trades.
America’s Generation Z is coming of age in a whole new world of weed.
This large cohort, which already has big-time spending power as the oldest age into high school and college, is formulating its consumption habits at a time when marijuana muscles into the mainstream. Unlike their Gen X or Boomer parents, Gen Z shoppers have only known a time where cannabis is edging toward acceptance, with California voting to legalize medical use in 1996—a year before even the oldest Gen Z consumers were born. Continue reading “Gen Z Will Be the Ultimate Pot Consumers”→